Three BriaCell posters and one publish-only abstract highlight robust clinical data from Bria-IMT™ and Bria-OTS™ studies in ...

| When clinical trial steps are managed separately, the study suffers from compounded delays. Discover proven solutions from ...

A phase II clinical trial led by the Alliance for Clinical Trials in Oncology has met its primary endpoint, demonstrating ...

The FDA ordered a clinical hold on Rocket Pharmaceuticals' Danon disease trial after the adverse event was first disclosed.

START and OneOncology launch 3 new early-phase trial sites, expanding access to new cancer research in community oncology ...

For more information about Syncromune, please visit www.syncromune.com.

A pre-surgical combination therapy including pembrolizumab plus dabrafenib and trametinib (DTP) significantly improved ...

Augustine Therapeutics has initiated subject dosing in the randomised Phase I trial of AGT-100216 for Charcot-Marie-Tooth ...

The findings suggest that "the heightened focus on alternative endpoints, now representing the most common primary endpoint, ...

Auron Therapeutics begins patient dosing in phase 1 trial of AUTX-703 in advanced hematologic malignancies: Newton, Massachusetts Monday, June 2, 2025, 16:00 Hrs [IST] Auron Thera ...

The SWOG S2302 Pragmatica-Lung trial, which broke new ground with its streamlined pragmatic design, unusually broad ...